Less Invasive Surfactant Administration in Late Preterm or Early Term Born Infants
Recruiting
N/A
Interventional Study
Respiratory Distress Syndrome
Preterm Pregnancy
Surfactant Deficiency Syndrome Neonatal
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 34 Weeks – 38 Weeks
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 245 (estimated)
- Sponsor
- King's College Hospital NHS Trust · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to see if giving less invasive surfactant administration (LISA) during high-flow nasal cannula (HFNC) oxygen treatment reduces the need for invasive ventilation in babies with breathing problems born 2-6 weeks early.
Less invasive surfactant administration is where surfactant (a naturally produced substance which helps open up the tiny air sacs in the lungs making it easi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Infants born at 34+0 to 38+6 weeks of gestation, requiring resuscitation at birth, but who achieve regular spontaneous breathing and have a heart rate over 100 beats per minute while receiving non-invasive support.
* Infants enrolled in the Surfon trial, born at 34+0 to 38+6 w…
Contacts